Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2013World Journal of Gastrointestinal Pharmacology and TherapeuticsOpen Access

Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition

View Full Paper
Ask AI
Bookmark
Share

Authors

IBIan Leonard Phillip BealesAHAbigail HensleyYLYoon K. LokeUniversity of East Anglia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Beales et al. (2013) studied this question.

synapsesocial.com/papers/6aa50d69f197b883c13d696chttps://doi.org/10.4292/wjgpt.v4.i3.69
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mortality Associated with Barrett's Esophagus and Gastroesophageal Reflux Disease Diagnoses-A Population-Based Cohort Study2005 · 65 citations
  2. 2Statins Inhibit Proliferation and Induce Apoptosis in Barrett's Esophageal Adenocarcinoma Cells2008 · 148 citations
  3. 3Exposure to statins and risk of common cancers: a series of nested case-control studies2011 · 139 citations
  4. 4Statin use and cancer risk: a comprehensive review2010 · 278 citations
  5. 5Estimates of worldwide burden of cancer in 2008: GLOBOCAN 20082010 · 21,412 citations